We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in the Offing for Mettler-Toledo's (MTD) Q4 Earnings?
Read MoreHide Full Article
Mettler-Toledo International, Inc. (MTD - Free Report) is scheduled to report fourth-quarter 2021 results on Feb 10.
For the fourth quarter, the company anticipates year-over-year sales growth of 8% in local currency. The Zacks Consensus Estimate for the same is pegged at $1.02 billion, indicating growth of 8.7% from the year-ago reported figure.
Adjusted quarterly earnings are anticipated to be $10-$10.05 per share, implying an 8-9% rise from the prior-year quarter’s reported figure. The consensus mark for the same is pegged at $10.07 per share, suggesting a rise of 8.6% from the year-ago quarter.
We note the company surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average beat being 8.51%.
MettlerToledo International, Inc. Price and EPS Surprise
Mettler-Toledo’s portfolio strength, cost-cutting efforts, robust sales and marketing strategies, and margin and productivity initiatives are expected to have aided the fourth-quarter performance.
The company’s solid momentum across the Laboratory and Industrial segments is expected to get reflected in the soon-to-be-reported quarterly results.
MTD’s investments in product portfolio expansion, field force, Spinnaker sales and marketing programs are likely to have driven sales growth in the Laboratory Instruments segment. Strong momentum across pharmaceutical and life sciences markets is expected to have benefited the segment in the quarter under review. The company’s strong analytical instruments portfolio is anticipated to have contributed well.
Solid COVID-related testing demand and the favorable biopharma trend are likely to have been key catalysts for the Laboratory segment in the fourth quarter.
Robust automated chemistry solutions are expected to have aided Mettler-Toledo’s momentum across the drug process development field in the quarter under discussion.
The growing momentum across the core industrial business is likely to have driven the Industrial Instruments segment’s sales in the to-be-reported quarter.
However, sluggishness in the company’s Food Retail segment is expected to get reflected in the upcoming results.
Additionally, headwinds related to the coronavirus pandemic are likely to have continued posing challenges to the company in the soon-to-be-reported quarter. Softness in the product inspection business is expected to have hurt.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for Mettler-Toledo this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Mettler-Toledo has an Earnings ESP of 0.00% and a Zacks Rank #2.
Stocks to Consider
Here are some stocks that you may consider as our model shows that these have the right combination of elements to beat on earnings this season.
Endava is scheduled to release second-quarter fiscal 2022 results on Feb 16. The Zacks Consensus Estimate for DAVA’s earnings is pegged at 59 cents per share, suggesting an increase of 55.3% from the prior-year reported figure.
Monolithic Power Systems (MPWR - Free Report) has an Earnings ESP of +2.83% and a Zacks Rank #2 at present.
Monolithic Power Systems is set to report fourth-quarter 2021 results on Feb 10. The Zacks Consensus Estimate for MPWR’s earnings is pegged at $1.87 per share, which suggests an increase of 42.8% from the prior-year reported figure.
Analog Devices (ADI - Free Report) has an Earnings ESP of +0.25% and a Zacks Rank #2 at present.
Analog Devices is scheduled to release first-quarter fiscal 2022 results on Feb 16. The Zacks Consensus Estimate for ADI’s earnings is pegged at $1.79 per share, which suggests an increase of 24.3% from the prior-year reported figure.
Image: Bigstock
What's in the Offing for Mettler-Toledo's (MTD) Q4 Earnings?
Mettler-Toledo International, Inc. (MTD - Free Report) is scheduled to report fourth-quarter 2021 results on Feb 10.
For the fourth quarter, the company anticipates year-over-year sales growth of 8% in local currency. The Zacks Consensus Estimate for the same is pegged at $1.02 billion, indicating growth of 8.7% from the year-ago reported figure.
Adjusted quarterly earnings are anticipated to be $10-$10.05 per share, implying an 8-9% rise from the prior-year quarter’s reported figure. The consensus mark for the same is pegged at $10.07 per share, suggesting a rise of 8.6% from the year-ago quarter.
We note the company surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average beat being 8.51%.
MettlerToledo International, Inc. Price and EPS Surprise
MettlerToledo International, Inc. price-eps-surprise | MettlerToledo International, Inc. Quote
Key Factors to Consider
Mettler-Toledo’s portfolio strength, cost-cutting efforts, robust sales and marketing strategies, and margin and productivity initiatives are expected to have aided the fourth-quarter performance.
The company’s solid momentum across the Laboratory and Industrial segments is expected to get reflected in the soon-to-be-reported quarterly results.
MTD’s investments in product portfolio expansion, field force, Spinnaker sales and marketing programs are likely to have driven sales growth in the Laboratory Instruments segment. Strong momentum across pharmaceutical and life sciences markets is expected to have benefited the segment in the quarter under review. The company’s strong analytical instruments portfolio is anticipated to have contributed well.
Solid COVID-related testing demand and the favorable biopharma trend are likely to have been key catalysts for the Laboratory segment in the fourth quarter.
Robust automated chemistry solutions are expected to have aided Mettler-Toledo’s momentum across the drug process development field in the quarter under discussion.
The growing momentum across the core industrial business is likely to have driven the Industrial Instruments segment’s sales in the to-be-reported quarter.
However, sluggishness in the company’s Food Retail segment is expected to get reflected in the upcoming results.
Additionally, headwinds related to the coronavirus pandemic are likely to have continued posing challenges to the company in the soon-to-be-reported quarter. Softness in the product inspection business is expected to have hurt.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for Mettler-Toledo this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Mettler-Toledo has an Earnings ESP of 0.00% and a Zacks Rank #2.
Stocks to Consider
Here are some stocks that you may consider as our model shows that these have the right combination of elements to beat on earnings this season.
Endava (DAVA - Free Report) has an Earnings ESP of +0.85% and a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Endava is scheduled to release second-quarter fiscal 2022 results on Feb 16. The Zacks Consensus Estimate for DAVA’s earnings is pegged at 59 cents per share, suggesting an increase of 55.3% from the prior-year reported figure.
Monolithic Power Systems (MPWR - Free Report) has an Earnings ESP of +2.83% and a Zacks Rank #2 at present.
Monolithic Power Systems is set to report fourth-quarter 2021 results on Feb 10. The Zacks Consensus Estimate for MPWR’s earnings is pegged at $1.87 per share, which suggests an increase of 42.8% from the prior-year reported figure.
Analog Devices (ADI - Free Report) has an Earnings ESP of +0.25% and a Zacks Rank #2 at present.
Analog Devices is scheduled to release first-quarter fiscal 2022 results on Feb 16. The Zacks Consensus Estimate for ADI’s earnings is pegged at $1.79 per share, which suggests an increase of 24.3% from the prior-year reported figure.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.